Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 136,172	$ 125,189
Restricted cash equivalents	97	5,577
Marketable securities, at fair value	42,442	42,774
Restricted marketable securities, at fair value	35,898	30,352
Accounts receivable, net (less allowances: $120,089 and $119,305)	299,443	281,303
Notes receivable — short–term portion, net (less allowances: $$27,696 and $$25,931)	29,068	31,243
Inventories and supplies	15,891	16,797
Taxes receivable	14,227	22,246
Prepaid expenses and other current assets	27,992	20,934
Total current assets	601,230	576,415
Property and equipment, net	27,032	27,586
Goodwill	79,797	79,797
Other intangible assets (less accumulated amortization of $43,580 and $42,931)	6,315	6,964
Notes receivable — long–term portion, net (less allowances: $1,953 and $1,776)	20,628	25,209
Deferred compensation funding, at fair value	52,995	55,909
Deferred tax assets	17,967	18,472
Other long-term assets	8,881	3,901
Total assets	814,845	794,253
Current liabilities:
Accounts payable	83,124	77,382
Accrued payroll and related taxes	50,043	31,400
Other accrued expenses and current liabilities	37,718	37,222
Accrued insurance claims	22,481	24,371
Total current liabilities	193,366	170,375
Accrued insurance claims — long-term	43,822	46,142
Deferred compensation liability — long-term	52,934	56,276
Lease liability — long-term	9,363	9,659
Other long-term liabilities	1,594	1,591
Commitments and contingencies (Note 17)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 200,000 shares authorized; 77,270 and 76,821 shares issued, and 68,931 and 69,596 shares outstanding	773	768
Additional paid-in capital	328,745	327,956
Retained earnings	309,731	283,668
Accumulated other comprehensive loss, net of taxes	(835)	(448)
Common stock in treasury, at cost, 8,339 and 7,225 shares	(124,648)	(101,734)
Total stockholders’ equity	513,766	510,210
Total liabilities and stockholders’ equity	$ 814,845	$ 794,253